• 1. An artificial blood vessel implanted three-dimensional microsystem for modeling transvascular migration of tumor cells?
  Xue-Ying Wang,Ying Pei,Min Xie,Zi-He Jin,Ya-Shi Xiao,Yang Wang,Li-Na Zhang,Yan Li,Wei-Hua Huang Lab Chip, 2015,15, 1178-1187
• 2. An investigation into the origin of variations in photovoltaic performance using D–D–π–A and D–A–π–A triphenylimidazole dyes with a copper electrolyte?
  Govind Reddy Mol. Syst. Des. Eng., 2021,6, 779-789
• 3. An algal process treatment combined with the Fenton reaction for high concentrations of amoxicillin and cefradine
  Haitao Li,Yu Pan,Zhizhi Wang,Shan Chen,Ruixin Guo,Jianqiu Chen RSC Adv., 2015,5, 100775-100782
• 4. An insight into the role of side chains in the microstructure and carrier mobility of high-performance conjugated polymers?
  Jianyao Huang,Dong Gao,Zhihui Chen,Weifeng Zhang Polym. Chem., 2021,12, 2471-2480
• 5. An assessment of strategies for the development of solid-state adsorbents for vehicular hydrogen storage
  Mark D. Allendorf,Alauddin Ahmed,Tom Autrey,Jeffrey Camp,Eun Seon Cho,Maciej Haranczyk,Abhi Karkamkar,Di-Jia Liu,Katie R. Meihaus,Iffat H. Nayyar,Roman Nazarov,Donald J. Siegel,Vitalie Stavila,Jeffrey J. Urban,Srimukh Prasad Veccham,Brandon C. Wood Energy Environ. Sci., 2018,11, 2784-2812

Comprehensive Guide to 2H-1,5-Benzodioxepin, 3,4-dihydro-6-methoxy- (CAS No. 76921-14-7): Properties, Applications, and Market Insights

2H-1,5-Benzodioxepin, 3,4-dihydro-6-methoxy- (CAS No. 76921-14-7) is a specialized organic compound that has garnered significant attention in pharmaceutical and chemical research. This heterocyclic molecule features a benzodioxepin core, which is known for its versatility in drug design and material science. With the growing demand for novel bioactive compounds, researchers are increasingly exploring the potential of 3,4-dihydro-6-methoxy-2H-1,5-benzodioxepin in therapeutic applications.

The molecular structure of 2H-1,5-Benzodioxepin, 3,4-dihydro-6-methoxy- includes a seven-membered dioxepin ring fused to a benzene moiety, with a methoxy group at the 6-position. This unique architecture contributes to its stability and reactivity, making it a valuable intermediate in synthetic chemistry. Recent studies highlight its role in the development of central nervous system (CNS) agents, owing to its ability to modulate neurotransmitter activity. Such properties align with current trends in neuroscience research, where neuroprotective compounds and cognitive enhancers are highly sought after.

In the pharmaceutical industry, 76921-14-7 is often utilized as a building block for psychoactive drugs and antidepressants. Its structural similarity to naturally occurring benzodioxole derivatives allows it to interact with biological targets such as serotonin and dopamine receptors. This has led to its inclusion in preclinical studies for mood disorders and neurodegenerative diseases—a hot topic given the rising global prevalence of mental health conditions. Researchers are also investigating its potential as a precursor for green chemistry applications, reflecting the industry's shift toward sustainable synthesis methods.

The commercial market for 3,4-dihydro-6-methoxy-2H-1,5-benzodioxepin is expanding, driven by its demand in contract research organizations (CROs) and academic laboratories. Analytical techniques like HPLC and NMR spectroscopy are commonly employed to characterize its purity, a critical factor given its use in high-value research. Suppliers often highlight its low toxicity profile and solubility in organic solvents, addressing common queries from buyers about handling and storage.

From an SEO perspective, this compound attracts searches related to "benzodioxepin synthesis", "CAS 76921-14-7 suppliers", and "methoxy-substituted heterocycles". These keywords reflect the interests of chemists and procurement specialists seeking technical data or commercial sources. Environmental considerations also play a role; queries like "biodegradability of benzodioxepin derivatives" indicate growing awareness of eco-friendly chemistry practices.

Future prospects for 2H-1,5-Benzodioxepin, 3,4-dihydro-6-methoxy- include its potential integration into catalysis and photodynamic therapy—areas gaining traction due to advances in renewable energy and precision medicine. Its compatibility with microwave-assisted synthesis (a trending lab technique) further enhances its appeal. As regulatory frameworks evolve, documentation of its structure-activity relationships (SAR) will be crucial for patent applications and safety assessments.

In summary, 76921-14-7 represents a multifaceted compound bridging medicinal chemistry and industrial applications. Its alignment with contemporary scientific priorities—such as mental health therapeutics and green synthesis—positions it as a compound of enduring relevance. For researchers and suppliers alike, staying updated on its latest developments is key to leveraging its full potential.

• 2098070-20-1(2-(3-(Pyridin-3-yl)-1H-pyrazol-1-yl)acetimidamide)
• 2680771-01-9(4-cyclopentyl-3-{(prop-2-en-1-yloxy)carbonylamino}butanoic acid)
• 1444113-98-7(N-(3-cyanothiolan-3-yl)-2-[(2,2,2-trifluoroethyl)sulfanyl]pyridine-4-carboxamide)
• 332062-08-5(Fmoc-S-3-amino-4,4-diphenyl-butyric acid)
• 1270529-38-8(1,2,3,4,5,6-Hexahydro-[2,3]bipyridinyl-6-ol)
• 941977-17-9(N'-(3-chloro-2-methylphenyl)-N-2-(dimethylamino)-2-(naphthalen-1-yl)ethylethanediamide)
• 2138166-62-6(2,2-Difluoro-3-[methyl(2-methylbutyl)amino]propanoic acid)
• 89640-58-4(2-Iodo-4-nitrophenylhydrazine)
• 1449132-38-0(3-Fluoro-5-(2-fluoro-5-methylbenzylcarbamoyl)benzeneboronic acid)
• 2034271-14-0(2-(1H-indol-3-yl)-N-{[6-(thiophen-2-yl)-[1,2,4]triazolo[4,3-b]pyridazin-3-yl]methyl}acetamide)